Infusion Billing FAQs

Quick Answers for Infusion Providers


Get clear answers to infusion billing FAQs covering prior authorizations, coding requirements, reimbursement rates, and denial management. Simplify complex billing challenges with expert guidance tailored for infusion providers.

➜100% HIPAA Compliant
➜99% Ensure Accuracy
➜100% Client Satisfaction
➜99% Clean Claim Rate
➜35% Revenue Increase
➜99% First Pass Rate
➜Multi-Specialty Experts
➜100% HIPAA Compliant
➜99% Ensure Accuracy
➜100% Client Satisfaction
➜99% Clean Claim Rate
➜35% Revenue Increase
➜99% First Pass Rate
➜Multi-Specialty Experts

Check the answers to Infusion BillingΒ FAQs



Medical Billing & Codings

1How do you handle medical necessity documentation gaps?
We compare the clinical notes with the payer criteria, pinpoint the missing pieces of evidence, and work with providers to get the supporting documentation such as lab results or the doctor's explanation of the treatment before filing the claim.
2What is your modifier strategy for infusion claims?
We dissect each case to decide which modifiers to use, keep ourselves informed about CCI edits and payer policies, and perform audits to increase the reimbursement without losing compliance.
3How do you manage J-code and HCPCS updates?
We are on top of the changes to the codes every quarter, have subscriptions to different coding resources, instantly change our database, and prepare our employees so that the claims will have the most recent codes and will not be β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œrejected.

Complete Practice Management

1How do you streamline workflows for infusion practices?
We dive deep into current operations, pinpointing bottlenecks through our thorough analysis. Our infusion practices benefit wonderfully from efficient scheduling systems that we have implemented. On top of that, we have optimized staff responsibilities, standardized documentation protocols, upgraded communication, and integrated technology solutions that significantly reduce the administrative burden and save time for patient throughput.
2What metrics do you track for practice performance?
It is our practice to keep an eye on collection rates, days in AR, denial percentages, patient volume trends, staff productivity, reimbursement patterns, and payer performance. These are the key areas that reveal actionable insights for the management of the practice to make informed decisions.
3How do you optimize patient scheduling and capacity?
We study appointment patterns to reveal the inefficiencies, then adopt efficient scheduling templates to address them. By cutting no-show rates to almost zero, we are able to utilize appointment slots to the maximum and thus maximize chair utilization. Provider workloads are balanced, and we are able to create systems that improve patient flow and revenue capture by getting patients scheduled β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œappropriately.

Practice Credentialing

1How long does the credentialing process typically take?
It generally takes from 90 to 120 days to perform initial credentialing based on the requirements of the payer. In order to reduce the waiting time and revenue losses, we expedite applications, follow up proactively, track deadlines, and communicate status updates.
2What happens if credentialing applications get denied or delayed?
Upon a denial, we determine the reasons right away, fix any errors in the application, submit missing pieces of documentation, appeal decisions if it is the case, and cooperate with payer representatives to resolve issues and speed up approval processes.
3How do you manage recredentialing and provider updates?
We keep credentialing calendars, file renewal applications before the date of expiration, update provider information with all payers, monitor CAQH profiles, and maintain network participation to avoid claim β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œdenials.

Benefits & Eligibility Verification

1How do you confirm that infusion therapy is covered in an accurate manner?
Directly, we communicate with payers, scrutinize plan documents, confirm infusion benefits, administration coverage, check the site of service for requirements, identify copays and deductibles, and record everything before treatment.
2What details do you share in verification reports?
We give a full account of the covered services, prior authorization requirements, medical necessity criteria, patient financial responsibility, copay amounts, deductible status, out-of-pocket maximum, and any coverage limitations or exclusions.
3How do you resolve differences in benefit information?
We get in touch with payer representatives without delay, ask for confirmation in writing, bring unresolved issues to the management, document all our communications, get reference numbers, and double-check information before scheduling treatments so as not to have a claim.

Claims Management

1How do you reduce claim denials for infusions?
To reduce denials, we take various measures such as scrubbing claims before submission, ensuring coding accuracy, checking the patient’s eligibility, attaching the necessary documentation, following the payer’s guidelines, using the correct modifiers, and making sure that medical necessity is clearly supported.
2What is your process for tracking unpaid claims?
We keep a close eye on the daily aging reports of unpaid claims, follow up in a timely and organized manner at specific intervals, escalate those that are overdue, contact the payer representatives from whom we expect a response, keep a record of all the conversations, and, if necessary, we finally request the resolution of the payment through an appeal.
3How quickly do you resubmit corrected or denied claims?
We respond to denial reasons without delay, correct errors within 24 hours, and if necessary, we gather additional documentation sooner rather than later. After that, we resubmit claims without delay, and we are very diligent in tracking our resubmissions so that we do not run into timely filing limit issues and losing β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œrevenue.

AR & Denial Management

1How do you handle CO-50 denials from payers?
First, we distinguish between truly non-covered services that have been denied and those in which the payer has given us an incorrect denial. Then, we verify the Local Coverage Determination (LCD) requirements. If needed, we resubmit the claims with the correct modifiers. In case of an appeal, we provide the medical necessity documentation that refers to the specific policy language.
2What strategies reduce timely filing limit claim losses?
We set up automated aging alerts that trigger at 60 and 75 days, respectively, and thus are able to prioritize claims according to payer deadlines. Furthermore, we expedite requests for missing information, help resolve the accounts of claims that are stalled by issuing them to supervisors, and keep a detailed database of filing deadlines.
3How do you manage payer downcoding of infusion services?
Initially, we reconcile procedure codes that were submitted with those that were paid. Thereafter, we locate recurring instances where there are systematic patterns of downcoding, and then we work to get those incorrect reductions reversed by providing support documentation. In addition, we engage in fee schedule correction negotiations, and when necessary, we file corrected claims or formal β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œappeals.

Efficient Payment Posting

1How do you manage complex ERA reconciliation problems?
We carefully connect each line item on the ERA claim with the corresponding charge details, look into payment variances, pinpoint segregation or downcoding, match contractual changes with fee schedules, and record underpayments for the immediate follow-up.
2What method do you use to record partial payments?
We assign payments to particular service lines, figure out denial reasons for the unpaid portions, correctly change balances between payers for COB, accurately update aging buckets, and place the denied amounts in the appeal workflow queue.
3How do you ensure posting accuracy for infusions?
We confirm the reimbursement rates for the J-codes according to the contracts, ensure that the correct administration codes are paid, check the effect of the modifier on the reimbursement, make sure that the payments for the drug waste are balanced, and systematically conduct an audit of the posted amounts against the expected β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œreimbursement.

Multi Specialties

1How is the billing of DMARD infusion handled for rheumatologists?
An accurate coding of biologic therapy using the right J-codes is what we do. Alongside this, we ensure that the documentation supports the use of the therapy for diseases like rheumatoid arthritis or psoriatic arthritis. We also check if the patient is following the step therapy, and if it is so, we attach the prior authorizations. In case of a denial, we appeal it by citing disease severity.
2What are the difficulties in the billing of chemotherapy infusions for oncologists?
Management of intricate multi-drug regimens is among the things we handle. We also do the wastage calculation and billing correctly by using JW modifiers. Besides, we verify if supportive medications are bundled or separately billable. To add to that, we deal with buy-and-bill reimbursement timing issues and make sure that the sequencing is properly documented.
3How do you bill infliximab biosimilars for gastroenterologists?
One of the things we do is the correct use of J-codes for originator as well as biosimilar products. We also have the medical justification when the brand is chosen. Payer biosimilar policies and preferred products are verified by us. Besides, we manage step therapy requirements and, in case a substitution is denied, we appeal the denial.
4What kind of coding problems come with IVIG for neurologists?
We ensure to have very clear documentation of the medical necessity of neurological diagnoses, such as CIDP or myasthenia gravis, when the use of IVIG is the case. We also do calculations of the total grams given. Besides, we verify infusion coverage, whether it is at home or in the office. We manage very costly prior authorization requirements and, in case of dosing denials, we appeal β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œthem.
5How do you maximize reimbursement for monoclonal antibody infusions?
We do all these: selecting the right administration code depending on infusion time, recording initial and sequential infusions properly, checking concurrent infusion rules, using hierarchy modifiers correctly, and not missing any pushing or extra hour codes that can be billed.
6What prior authorization strategies work for immunology infusions?
We are doing all these to get authorization rapidly: submitting full clinical documentation right from the start, including lab values supporting disease activity, citing FDA-approved indications and payer medical policies, providing previous treatment trials when asked, and putting through urgent authorization requests quickly.
7How do you handle weight-based dosing documentation requirements?
We make sure that the chart notes show the current patient weight, that the milligrams per kilogram are calculated correctly, that the dose rounding method is documented, that any dose changes from standard are justified, and that payer auditing standards are followed.
8What reimbursement differences exist between office and hospital infusions?
We do all these to understand the differences in reimbursement: knowing the details of facility fees versus professional-only billing, dealing with place of service requirements, handling split billing situations, checking patient out-of-pocket cost changes, and advising providers on the financial impact for their practice β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œrevenue.
9How do you challenge medical necessity denials for specialty infusions?
Our team retrieves specific clinical notes that describe the severity of the disease, gathers lab and imaging results, cites peer-reviewed articles that support the treatment, refers to the LCD/NCD criteria in detail, drafts the appeal letters in detail, and, if necessary, moves the case to an external β€‹β€β€‹β€Œβ€β€‹β€β€Œβ€‹β€β€‹β€Œβ€β€‹β€β€Œreview.